| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Leukocyte Adhesion Laboratory, Imperial Cancer Research Fund, London, England
Correspondence: Dr. N. Hogg, Leukocyte Adhesion Laboratory, Imperial Cancer Research Fund, Lincoln’s Inn Fields, London WC2A 3PX, England. E-mail: hogg{at}icrf.icnet.uk
Integrin activity on leukocytes is controlled tightly, ensuring that
ligand binding occurs only when leukocytes are in contact with their
targets. For an integrinlike LFA-1, this ligand-binding activity comes
about as a result of increased integrin clustering. Affinity regulation
of integrins also plays a role, but the conformational changes giving
rise to increased affinity appear to be secondary to clustering.
Conformationally altered LFA-1 can be created artificially by deletion
of the I domain, which is the key domain involved in ligand binding for
many but not all integrins. Although I domain-deleted LFA-1
(
I-LFA-1) cannot bind ligand, it is able to signal constitutively
into the cell. One measure of this signaling activity is the ability of
I-LFA-1 to activate ß1 integrins on the same T lymphocyte.
Leukocytes use LFA-1 to migrate across the endothelium. Active ß1
integrins may be required subsequently to bind the matrix proteins
encountered by leukocytes as they continue their voyage into the tissue
interior.
Key Words: integrin structure • integrin activation • I domain
This article has been cited by other articles:
|
|
 |
|
  A. A. Canalli, C. F. Franco-Penteado, S. T.O. Saad, N. Conran, and F. F. Costa Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation Haematologica, April 1, 2008; 93(4): 605 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Varga, S. Balkow, M. K. Wild, A. Stadtbaeumer, M. Krummen, T. Rothoeft, T. Higuchi, S. Beissert, K. Wethmar, K. Scharffetter-Kochanek, et al. Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation Blood, January 15, 2007; 109(2): 661 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Barthel, D. S. Annis, D. F. Mosher, and M. W. Johansson Differential Engagement of Modules 1 and 4 of Vascular Cell Adhesion Molecule-1 (CD106) by Integrins {alpha}4beta1 (CD49d/29) and {alpha}Mbeta2 (CD11b/18) of Eosinophils J. Biol. Chem., October 27, 2006; 281(43): 32175 - 32187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Brandsma, L. Ulfman, J. C. Reijneveld, M. Bracke, M. J.B. Taphoorn, J. J. Zwaginga, M. F.B. Gebbink, H. de Boer, L. Koenderman, and E. E. Voest Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases Neuro-oncol, April 1, 2006; 8(2): 127 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Heit, P. Colarusso, and P. Kubes Fundamentally different roles for LFA-1, Mac-1 and {alpha}4-integrin in neutrophil chemotaxis J. Cell Sci., November 15, 2005; 118(22): 5205 - 5220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yonekawa and J. M. Harlan Targeting leukocyte integrins in human diseases J. Leukoc. Biol., February 1, 2005; 77(2): 129 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Kanse, R. L. Matz, K. T. Preissner, and K. Peter Promotion of Leukocyte Adhesion by a Novel Interaction Between Vitronectin and the {beta}2 Integrin Mac-1 ({alpha}M{beta}2, CD11b/CD18) Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2251 - 2256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Stroud and J. A. Wells Mechanistic Diversity of Cytokine Receptor Signaling Across Cell Membranes Sci. Signal., May 4, 2004; 2004(231): re7 - re7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Denti, A. Sirri, A. Cheli, L. Rogge, G. Innamorati, S. Putignano, M. Fabbri, R. Pardi, and E. Bianchi RanBPM Is a Phosphoprotein That Associates with the Plasma Membrane and Interacts with the Integrin LFA-1 J. Biol. Chem., March 26, 2004; 279(13): 13027 - 13034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jongstra-Bilen, R. Harrison, and S. Grinstein Fc{gamma}-receptors Induce Mac-1 (CD11b/CD18) Mobilization and Accumulation in the Phagocytic Cup for Optimal Phagocytosis J. Biol. Chem., November 14, 2003; 278(46): 45720 - 45729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Greening, T. I.M. Tree, K. T. Kotowicz, A. G. van Halteren, B. O. Roep, N. J. Klein, and M. Peakman Processing and Presentation of the Islet Autoantigen GAD by Vascular Endothelial Cells Promotes Transmigration of Autoreactive T-Cells Diabetes, March 1, 2003; 52(3): 717 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xia, G. Borland, J. Huang, I. F. Mizukami, H. R. Petty, R. F. Todd III, and G. D. Ross Function of the Lectin Domain of Mac-1/Complement Receptor Type 3 (CD11b/CD18) in Regulating Neutrophil Adhesion J. Immunol., December 1, 2002; 169(11): 6417 - 6426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Heit, S. Tavener, E. Raharjo, and P. Kubes An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients J. Cell Biol., October 14, 2002; 159(1): 91 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dewitt and M. B. Hallett Cytosolic free Ca2+ changes and calpain activation are required for {beta} integrin-accelerated phagocytosis by human neutrophils J. Cell Biol., October 14, 2002; 159(1): 181 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Decleva, P. Dri, R. Menegazzi, S. Busetto, and R. Cramer Evidence that TNF-induced respiratory burst of adherent PMN is mediated by integrin {alpha}L{beta}2 J. Leukoc. Biol., October 1, 2002; 72(4): 718 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Welzenbach, U. Hommel, and G. Weitz-Schmidt Small Molecule Inhibitors Induce Conformational Changes in the I Domain and the I-like Domain of Lymphocyte Function-associated Antigen-1. MOLECULAR INSIGHTS INTO INTEGRIN INHIBITION J. Biol. Chem., March 15, 2002; 277(12): 10590 - 10598. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
